Filtered By:
Condition: Thrombosis
Countries: Iran Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 72 results found since Jan 2013.
Cutaneous microvascular occlusion syndrome as the first manifestation of catastrophic lupus-associated antiphospholipid antibody syndrome: a case report
ConclusionAPS in pediatrics, is associated with a variety of neurologic, dermatologic, and hematologic symptoms. Therefore, it is essential for pediatricians to be aware of the rare appearance of Catastrophic APS as an initial indication of APS.
Source: Journal of Medical Case Reports - August 22, 2023 Category: General Medicine Source Type: research
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis
Antiplatelet drugs, such as Aspirin and Clopidogrel (Plavix) are effective in the primary prevention of thromboembolic events. They are commonly used to reduce the risk of recurrence of thromboembolism. The bo...
Source: Thrombosis Journal - July 27, 2023 Category: Hematology Authors: Mohammad Parsa-kondelaji and Hassan Mansouritorghabeh Tags: Review Source Type: research
Investigating the prevalence of and predictive and risk factors for pulmonary embolism in patients with COVID-19 in Nemazee Teaching Hospital
CONCLUSION: Regression analysis revealed that age, blood pressure, heart attack, and albumin levels were independent predictors of PTE.PMID:37431097 | DOI:10.5045/br.2023.2023076
Source: Blood Research - July 11, 2023 Category: Hematology Authors: Mahnaz Yadollahi Hessam Hosseinalipour Muhammad Alinaqi Mehrdad Karajizadeh Mehrdad Jowkar Kazem Jamali Maryam Yadollahi Pooria Fazeli Source Type: research
The Hospitalization Rate of Cerebral Venous Sinus Thrombosis before and during COVID-19 Pandemic Era: A Single-Center Retrospective Cohort Study
CONCLUSION: Since there was a more dismal outcome in COVID-19 associated CVST, a high index of suspicion for CVST among COVID-19 positive is recommended.PMID:35523051 | PMC:PMC8947940 | DOI:10.1016/j.jstrokecerebrovasdis.2022.106468
Source: Atherosclerosis - May 6, 2022 Category: Cardiology Authors: Maryam Vasaghi Gharamaleki Maryam Habibagahi Etrat Hooshmandi Reza Tabrizi Shahram Arsang-Jang Zohreh Barzegar Nima Fadakar Vahid Reza Ostovan Abbas Rahimi-Jaberi Nahid Ashjazadeh Peyman Petramfar Maryam Poursadeghfard Sadegh Izadi Masoumeh Nazeri Hanieh Source Type: research
Anticoagulants for people hospitalised with COVID-19
CONCLUSIONS: When compared to a lower-dose regimen, higher-dose anticoagulants result in little to no difference in all-cause mortality and increase minor bleeding in people hospitalised with COVID-19 up to 30 days. Higher-dose anticoagulants possibly reduce pulmonary embolism, slightly increase major bleeding, may result in little to no difference in hospitalisation time, and may result in little to no difference in deep vein thrombosis, stroke, major adverse limb events, myocardial infarction, atrial fibrillation, or thrombocytopenia. Compared with no treatment, anticoagulants may reduce all-cause mortality but the evide...
Source: Cochrane Database of Systematic Reviews - March 4, 2022 Category: General Medicine Authors: Ronald Lg Flumignan Vinicius T Civile J éssica Dantas de Sá Tinôco Patricia If Pascoal Libnah L Areias Charbel F Matar Britta Tendal Virginia Fm Trevisani Álvaro N Atallah Luis Cu Nakano Source Type: research
